RCS - Braveheart Inv Group - Further update re Paraytec AD Scanner project

Braveheart InvestmentAnnouncement

04/08/2021 14:45

RNS Number : 5988H
  
Braveheart Investment Group plc
  
04 August 2021
  
 

Reach - a non-regulatory announcement
 
 4 August 2021
Braveheart Investment Group plc
("Braveheart" or the "Group")
Further update re Paraytec AD Scanner project
Further to the announcement on 14 June 2021, Braveheart Investment Group plc (AIM: BRH), regarding Paraytec's work with partners in the field of Alzheimer's disease (AD) detection and also the Covid-19 detection project.
 
Prototype instruments were shipped to project partners in early July 2021 and sample testing has commenced. The initial results from Vrije University Medical Centre Amsterdam (VUMC) using AD patient samples were inconclusive. The cause and implications of these initial results are not yet known. Further testing is needed and although the funded project will end at the end of this month, Paraytec's partners have indicated that they will continue the testing thereafter.  A further update is expected by the end of September 2021.
 
Paraytec's work to develop an instrument for the detection of COVID-19 is progressing as planned and a corporate finance specialist has been engaged to market the technology to potential partners or acquirers.
 
We anticipate releasing the next update for both the COVID-19 and AD scanner projects will be around the end of September 2021.
 
 
For further information:













Braveheart Investment Group plc


Tel: 01738 587555




Trevor Brown CEO


















Allenby Capital Limited (Nominated Adviser and Joint Broker)


Tel: 020 3328 5656




David Worlidge / James Reeve / George Payne


















Peterhouse Capital Limited (Joint Broker)


Tel: 020 7469 0936




Heena Karani / Lucy Williams







 
About Reach announcements
 
 
 
This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain.  Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.
 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
NRAXZLFBFVLXBBD